Back to CNTX
MARSHALL WACE, LLP CNTX Position History
Context Therapeutics Inc. • Healthcare
Quarters held
9
Latest value
$207K
Q2 2026
Peak value
$7.3M
First seen
Q4 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2024 | $64K |
| Q4 2024 | $150K |
| Q3 2025 | $35K |
| Q4 2025 | $110K |
| Q4 2025 | $3.7M |
| Q1 2026 | $406K |
| Q1 2026 | $7.3M |
| Q2 2026 | $5K |
| Q2 2026 | $207K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $207K | 375.8K | — | — |
| Q2 2026 | $5K | 8.7K | — | — |
| Q1 2026 | $7.3M | 2.79M | — | — |
| Q1 2026 | $406K | 154.9K | — | — |
| Q4 2025 | $3.7M | 2.52M | — | — |
| Q4 2025 | $110K | 75.1K | — | — |
| Q3 2025 | $35K | 35.8K | — | — |
| Q4 2024 | $150K | 142.5K | — | — |
| Q4 2024 | $64K | 60.8K | — | — |
Other funds holding CNTX
$4.8M
$3.7M
$3.6M
$3.1M
$2.6M